Are academia–pharma partnerships essential for novel drug discovery in the time of the COVID-19 pandemic?-Reference-Cited by-同舟云学术

Are academia–pharma partnerships essential for novel drug discovery in the time of the COVID-19 pandemic?

Published:2020-12-14 Issue:5 Volume:16 Page:475-479
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Lexchin Joel¹²³^ORCID

Affiliation:

1. Professor Emeritus, School of Health Policy and Management, York University, Toronto, ON, Canada

2. Associate Professor, Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada

3. Emergency Physician, University Health Network, Toronto, ON, Canada

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2021.1858794

Reference31 articles.

1. Hancock J Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing. Fortune; 2020 [cited 2020 Sep 13]. Available from: https://fortune.com/2020/08/24/oxford-astrazeneca-covid-vaccine-deal-pricing-profit-concerns/

2. Reuters Staff. Factbox: AstraZeneca’s potential coronavirus vaccine; 2020 [cited 2020 Sep 14]. Available from: https://www.reuters.com/article/us-health-coronavirus-astrazeneca-factbo/factbox-astrazenecas-potential-coronavirus-vaccine-idUSKBN25L1OH

3. The Real Story of Remdesivir. Public Citizen; 2020 May 7 [cited 2020 Nov 27]. Available from: https://www.citizen.org/article/the-real-story-of-remdesivir/

4. Access challenges to COVID-19 therapeutic candidates. MSF Access Campaign; 2020 Aug 24 [cited 2020 Nov 27]. Available from: https://msfaccess.org/sites/default/files/2020-09/MSF-AC_COVID_Rx_briefing-doc_Ed02-20200824_0.pdf

5. Mancini D, Kuchler H, Stacey K. Gliead asks to rescind special status for potential coronavirus drug. Financial Times. 2020 Mar 25.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID and structural cartelisation: market-state-society ties and the political economy of Pharma;New Political Economy;2024-01-19

2. Artificial intelligence–enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period;International Journal of Surgery;2023-03-02

3. Are patents important indicators of innovation for Chagas disease treatment?;Expert Opinion on Therapeutic Patents;2023-02-15